Repurposing of dipeptidyl peptidase FDA-approved drugs in Alzheimer’s disease using network pharmacology and in-silico approaches
Miah Roney, Md. Nazim Uddin, Azmat Ali Khan, Sabiha Fatima, Mohd Fadhlizil Fasihi Mohd Aluwi, S. M. Istiaque Hamim, Asrar Ahmad
Topics & Concepts
RepurposingDrug repositioningIn silicoDipeptidyl peptidase-4PharmacologyMolecular PharmacologyApproved drugDrugLinagliptinMedicineAlzheimer's diseaseSaxagliptinComputational biologyDrug discoveryDiseaseBioinformaticsSitagliptinBiologyType 2 diabetesDiabetes mellitusInternal medicineBiochemistryReceptorEndocrinologyEcologyGeneBioinformatics and Genomic NetworksAlzheimer's disease research and treatmentsMachine Learning in Bioinformatics